TD Cowen on Procept BioRobotics Corp (PRCT): 'In-Line Q1 Should Fuel Stock Rebound'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $34.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
